Tango Therapeutics, Inc. Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

TNGX

Peringkat dalam Saham #4543
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Harga Saham
$27.18
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$3.38B
Perubahan (1 hari)
-1.41%
Perubahan (1 tahun)
202.34%
Negara
US
Perdagangan Tango Therapeutics, Inc. (TNGX)

Kategori

Healthcare
Jumlah saham beredar untuk Tango Therapeutics, Inc. (TNGX)
Jumlah saham beredar per June 2026: 149.88M
Menurut laporan keuangan terbaru dan harga saham Tango Therapeutics, Inc., jumlah saham beredar saat ini adalah 149.88M. Pada akhir December 2023, perusahaan memiliki 94.57M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Tango Therapeutics, Inc. (TNGX) dari 2019 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 149.88M 37.22%
2024 109.23M 15.50%
2023 94.57M 7.69%
2022 87.82M 41.40%
2021 62.11M -29.00%
2020 87.47M 0.00%
2019 87.47M 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
253.90M 69.41%
US
396.00M 164.22%
US
478.91M 219.54%
AU
- -
CH
62.19M -58.51%
NL